Globe Newswire
The covered applications address potential therapeutic uses across a range of indications, including mental health disorders, such as depression and PTSD as well as substance use disorders
Vancouver, Canada, Sept. 23, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND) (the “Company”), a clinical-stage biopharmaceutical company advancing non-hallucinogenic psychedelic-derived neuroplastogen for scalable treatment of neuropsychiatric, metabolic, and... (continue reading...)
TORONTO and PERTH, Western Australia, Sept. 23, 2026 (GLOBE NEWSWIRE) -- Cygnus Metals Limited (ASX:CY5, TSXV:CYG, OTCQB: CYGGF) (“Cygnus” or the “Company”) provides the following update in relation to the proposed transaction under which Central Asia Metals PLC (AIM:CAML) (“CAML”) will acquire 100% of the shares in Cygnus pursuant to a scheme of arrangement under Part 5.1 of the Corporations Act 2001 (Cth) (“Scheme”).
Capitalised terms in this announcement that are... (continue reading...)
HONG KONG, Sept. 23, 2026 (GLOBE NEWSWIRE) -- 3 E Network Technology Group Limited (Nasdaq: MASK) (the “Company” or “3 E Network”), a business-to-business (“B2B”) information technology (“IT”) business solutions provider, committed to becoming a next-generation artificial intelligence (“AI”) infrastructure solutions provider, today announced that its Nordic strategic subsidiary and Finnish project entity, Aurora Core Technology Oy, has entered the substantive... (continue reading...)
- In the first peer-reviewed, real-world, contemporary, comparative effectiveness study of TTR stabilizers in ATTR-CM using U.S. claims data, acoramidis was associated with a statistically and clinically significant 34% reduction in a composite of clinical worsening events (diuretic intensification, heart failure hospitalization, and mortality) versus tafamidis (p=0.046), supporting improved clinical stability of acoramidis over tafamidis
- Acoramidis was also... (continue reading...)
TORONTO, Sept. 23, 2026 (GLOBE NEWSWIRE) -- DPM Metals Inc. (TSX: DPM, ASX: DPM) (ARBN: 689370894) (“DPM” or “the Company”) is pleased to announce the appointment of Peter Brady as Executive Vice President, General Counsel and Corporate Affairs, effective September 28, 2026.
“I am pleased to welcome Peter to DPM’s executive team. He brings a wealth of strategic legal expertise and proven leadership in navigating the complex regulatory and governance challenges facing... (continue reading...)
More Globe Newswire
View Older Stories-
Solera Commits to Becoming a Global Partner in China's New Energy Vehicle Industry's International Expansion, Following High-Level Meeting with CATARC
-
Solera Commits to Becoming a Global Partner in China's New Energy Vehicle Industry's International Expansion, Following High-Level Meeting with CATARC
-
VEON increases Share Buyback and Accelerates share cancellations
-
VEON increases Share Buyback and Accelerates share cancellations
-
Winnebago Industries to Announce Fourth Quarter and Fiscal 2026 Financial Results on October 21, 2026
-
Artelo Biosciences Files New Provisional Patent Application Covering ART27.13 for Obesity, Alone and in Combination with GLP-1 Receptor Agonists, Following Unexpected Nonclinical Findings
-
Cineplex Appoints Bill Walker as Chief Executive Officer and Announces Strategic Review
-
Brixton Metals Enters into Option Agreement to Acquire a 100% Interest in the Silver Focused Silvergruvan Project in Sweden
-
DEEP SEA MINERALS, WESTWIN SIGN NON-BINDING LETTER OF INTENT TO EVALUATE U.S. PROCESSING OF POLYMETALLIC NODULES
-
Southern Michigan Bancorp, Inc. Declares Cash Dividend
-
Entente Education Canada urges federal government to take steps to improve cash flow and tax fairness for seniors, caregiver support
-
Aventis Energy Announces Share Consolidation
-
Beneficient Announces Strategy to Eliminate HCLP Debt and Heppner Equity Interests
-
Brutus Mining Announces Listing on the Frankfurt Stock Exchange under the Symbol ZI3
-
Artiva Biotherapeutics Announces Oral Presentation of AlloNK® Clinical Data at the 17th International Symposium on Sjögren’s Disease
-
Wave Life Sciences Initiates Phase 2a Combination Trial of WVE-007 (GalNAc-siRNA) with Tirzepatide for Obesity
-
Form 8.3 - GAMMA COMMUNICATIONS PLC
-
AI Kill Switch: The Race to Control Rogue Frontier AI & AGI Models (Veterans First for America)
-
AI Kill Switch: The Race to Control Rogue Frontier AI & AGI Models (Veterans First for America)
-
SOPRIS TECHNOLOGIES Appoints Global Business Leader Robert Vrij to Board of Directors
-
Blueberry Strengthens MENA Presence with CMA Category 5 License and Dubai Office Launch
-
Nexentis: MitoCareX Evaluates Expanded Protein Capabilities to Enhance Flexibility and Support Future Drug Discovery
-
Biomea Fusion Announces Termination of Proposed Public Offering of Securities
-
TDG Outlines Multiple Kilometre-Plus-Scale Target Areas within Northwest Structural Corridor from the Aurora Complex
-
Talisker Begins Trading on the OTCQX Best Market
-
AGF Management Limited Declares Third Quarter 2026 Dividend
-
Presenting on Emerging Growth Conference 96 Day 2 on September 24. Register to live stream.
-
Classiq, Israel Natural Gas Lines and IonQ Advance Quantum Optimization for Natural Gas Networks
-
AC Immune Reports Positive Safety & Immunogenicity at week-100 in Part 1 of VacSYn Phase 2 Trial of ACI-7104
-
Auddia Announces Appointment of Former U.S. Secretary of Defense Mark T. Esper to LT350 Board of Directors
-
Grey Matters Announces the Closing of its Equity and Convertible Debenture Private Placement totalling CAD $1.12 Million
-
Photonic Inc. Advances Quantum Resource Estimation Capabilities with Microsoft
-
Loblaw September Food Inflation Report
-
Sleeping Giant Mine Activity Report
-
NexGold Intersects 14.07 g/t Gold over 7.0 Metres, 9.76 g/t Gold over 8.0 Metres and 2.84 g/t Gold over 13.0 Metres at the Goldlund Deposit, Ontario
-
MariMed Files Definitive Proxy Statement for Special Meeting of Stockholders to Approve Proposed Reverse Stock Split
-
Lexeo Therapeutics to Participate in the Stifel 2026 Virtual Cardiometabolic Forum
-
Inventus Expands Shallow High-Grade Main Layer and Identifies Broad Bulk-Tonnage Gold Potential at Pardo
-
Roivant Announces Topline Results from Proof-of-Concept Study of IMVT-1402 in Cutaneous Lupus Erythematosus
-
NIGERIA FULLY REPRESENTED AT 81ST UN GENERAL ASSEMBLY AS VICE PRESIDENT SHETTIMA LEADS DELEGATION
-
AskNicely Launches Claude Connector, Bringing Live Customer Feedback Directly Into Claude
-
Seer and Nanyang Technological University to Present Early Findings from Landmark PRECISE-SG100K Proteomics Study at HUPO 2026
-
Immunovant Announces Topline Results from Proof-of-Concept Study of IMVT-1402 in Cutaneous Lupus Erythematosus
-
Psyence BioMed Announces Strategic Ibogaine Investment
-
Verano to Report Third Quarter 2026 Financial Results on October 29, 2026
-
Green Thumb Industries to Report Third Quarter 2026 Financial Results on November 4, 2026
-
AGF Management Limited Reports Third Quarter 2026 Financial Results
-
CGS Immersive Introduces Cicero Orchestrator, a Governed AI Knowledge Engine for Workforce Readiness
-
Oruka Therapeutics Announces Positive Week 28 Data for ORKA-001 from the Ongoing EVERLAST-A Trial Showing Deepening of Responses Without Additional Dosing
-
Talisker Resources Ltd. Begins Trading on OTCQX Best Market
